Highlights

  • CSX reported FY25 revenue of AUD 19.8 million, marking a 26% increase year-on-year.
  • The company’s gross margin rose to 74.8%, while liquidity and debt ratios slightly improved.
  • For FY26, CSX expects over 20% revenue growth and plans reinvestment in operations.

CleanSpace Holdings Limited (ASX:CSX) is an Australian company specialising in the design, production, and sale of premium respiratory protection equipment for both industrial and healthcare applications. The company focuses on creating respirators and related products that deliver effective personal protection.

Financial Performance

For the financial period 2025 (FY25), the company reported revenue of AUD 19.8 million, representing a 26% YoY increase from AUD 15.7 million in FY24. Net loss improved to AUD 0.48 million in FY25 compared to AUD 3.13 million in the previous year, reflecting an 85% reduction YoY. Cash at bank increased to AUD 10.5 million in FY25 from AUD 9.8 million in FY24, marking a 7% YoY rise. The financial performance was supported by increased industrial market penetration, higher demand for consumables, expansion in the U.S. market, operational efficiencies, and careful cost management.

Business Update

On 28 October 2025, CSX issued a formal notice for its Annual General Meeting (AGM), which is scheduled to take place at 11:00 am AEDT on Friday, 28 November 2025. The meeting will be held at Unit 5, 39 Herbert Street, St Leonards, New South Wales.

On 7 November 2025, the company lodged an Appendix 2A to facilitate the quotation of 115,200 ordinary shares. These shares were converted from restricted share units following the cessation of transfer restrictions on 3 November 2025.

Key Positives and Negatives

In FY25, the company’s gross margin increased to 74.8% compared to 72.3% in FY24. During the same period the current ratio rose from 4.69x in FY24 to 5.08x. The debt-to-equity ratio increased from 0.18x in FY24 to 0.24x in FY25.

Business Outlook

For FY26, CSX anticipates annual revenue growth exceeding 20%, driven by ongoing industrial market penetration, an expanded sales presence, and sustained demand across both developed and emerging markets. Gross margins are expected to remain in the mid-70% range, which is projected to support continued positive EBITDA and cash flow through careful cost management and improved operational efficiency. The company also plans to reinvest in sales capacity, marketing activities, and research and development initiatives to enhance market share and strengthen its position in the industrial powered air-purifying respirator (PAPR) segment.

Share Performance of CSX

CSX’s shares were trading at AUD 0.70 per share on 19 November 2025 with an intraday gain of 0.72%. CSX’s stock has decreased by 14.11% in the last three months but increase by 55.53% over the six months and increased by 94.44% over the past year. CSX’s 52-week high is AUD 0.88, recorded on 08 August 2025, and 52-week low is AUD 0.305, recorded on 05 December 2024.

Support and Resistance Summary

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency, is 19 November 2025. The reference data in this report has been partly sourced from EODHD/Others.

 

Technical Indicators Defined:

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.